Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Madias

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
JACC. Case Reports|July 28, 2021
Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy: The Importance of Cardiac Magnetic Resonance ImagingDaniel R Feldman, Ethan J Rowin, Richard T Carrick, et al.
Journal of the American College of Cardiology|October 25, 2023
Etiology of Early-Onset Complete Atrioventricular Block and Use of Implanted Cardiac Electronic DevicesGilad Margolis, Jennifer Chee, Mark Kazatsker, et al.
The American Journal of Cardiology|July 12, 2020
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic CardiomyopathyEthan J Rowin, Aadhavi Sridharan, Christopher Madias, et al.
JACC. Clinical Electrophysiology|August 22, 2020
Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic CardiomyopathyMartin S Maron, Nathaniel Steiger, Austin Burrows, et al.
Circulation. Arrhythmia and Electrophysiology|September 8, 2020
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator ImplantsEthan J Rowin, Austin Burrows, Christopher Madias, et al.
Heart Rhythm|September 22, 2024
Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients With Hypertrophic CardiomyopathyEthan J Rowin, Gaurav Das, Christopher Madias, et al.
Drugs - Real World Outcomes|August 11, 2019
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting SystemMatthew S Duprey, Nada S Al-Qadheeb, Nick O'Donnell, et al.
The American Journal of Cardiology|April 21, 2010
Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapyJorge R Kizer, Christopher Madias, Brian Wilner, et al.
JACC. Clinical Electrophysiology|June 25, 2021
Accelerated Battery Depletion in Subcutaneous Implantable Cardioverter-DefibrillatorsChockalingam A Narayanan, Benjamin Katcher, Stephanie Coleman, et al.
The American Journal of Cardiology|April 20, 2020
Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic CardiomyopathyKartik R Kumar, Swati N Mandleywala, Christopher Madias, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
JACC. Case Reports|July 28, 2021
Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy: The Importance of Cardiac Magnetic Resonance ImagingDaniel R Feldman, Ethan J Rowin, Richard T Carrick, et al.
Journal of the American College of Cardiology|October 25, 2023
Etiology of Early-Onset Complete Atrioventricular Block and Use of Implanted Cardiac Electronic DevicesGilad Margolis, Jennifer Chee, Mark Kazatsker, et al.
The American Journal of Cardiology|July 12, 2020
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic CardiomyopathyEthan J Rowin, Aadhavi Sridharan, Christopher Madias, et al.
JACC. Clinical Electrophysiology|August 22, 2020
Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic CardiomyopathyMartin S Maron, Nathaniel Steiger, Austin Burrows, et al.
Circulation. Arrhythmia and Electrophysiology|September 8, 2020
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator ImplantsEthan J Rowin, Austin Burrows, Christopher Madias, et al.
Heart Rhythm|September 22, 2024
Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients With Hypertrophic CardiomyopathyEthan J Rowin, Gaurav Das, Christopher Madias, et al.
Drugs - Real World Outcomes|August 11, 2019
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting SystemMatthew S Duprey, Nada S Al-Qadheeb, Nick O'Donnell, et al.
The American Journal of Cardiology|April 21, 2010
Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapyJorge R Kizer, Christopher Madias, Brian Wilner, et al.
JACC. Clinical Electrophysiology|June 25, 2021
Accelerated Battery Depletion in Subcutaneous Implantable Cardioverter-DefibrillatorsChockalingam A Narayanan, Benjamin Katcher, Stephanie Coleman, et al.
The American Journal of Cardiology|April 20, 2020
Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic CardiomyopathyKartik R Kumar, Swati N Mandleywala, Christopher Madias, et al.
Pageof 8